Endevica Bio

Endevica Bio's lead candidate is a peptide therapeutic agent for the treatment of cachexia caused by cancer and other chronic diseases. Founded in 2009, the company aims to create best-in-class peptide candidates with superior safety and efficacy compared to other drugs in its class.